Overview

Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Primary objective of this study is to confirm the efficacy of HOE490 O (glimepiride/metformin) compared with placebo on top of glimepiride in HbA1c change. Secondary objectives of this study is to evaluate the safety of HOE490 O (glimepiride/metformin) compared with placebo on top of glimepiride as well as other efficacy parameters
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi
Treatments:
Glimepiride
Metformin